Konstantinos Stravodimos
Overview
Explore the profile of Konstantinos Stravodimos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
933
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Giannakodimos I, Kaltsas A, Moulavasilis N, Kratiras Z, Mitropoulos D, Chrisofos M, et al.
J Clin Med
. 2025 Jan;
14(2).
PMID: 39860459
: Multiparametric-Magnetic Resonance Imaging(mp-MRI) presents the ability to detect clinically significant cancer, aiming to avoid biopsy if the results are negative or target an abnormal lesion if a suspected lesion...
2.
Fragkoulis C, Bamias A, Gavalas N, Tzannis K, Fragiadis E, Pinitas A, et al.
Eur Urol
. 2025 Jan;
87(3):281-284.
PMID: 39827021
For patients with high-risk non-muscle-invasive bladder cancer (NMIBC) for whom bacillus Calmette-Guérin (BCG) treatment has failed, bladder preservation is a high priority. Immune checkpoint inhibitors have shown promise, but systemic...
3.
Katifelis H, Grammatikaki S, Zakopoulou R, Bamias A, Karamouzis M, Stravodimos K, et al.
In Vivo
. 2024 Dec;
39(1):146-151.
PMID: 39740865
Background/aim: Clear cell renal cell carcinoma (ccRCC) represents the most common type of renal cancer. When resectable, nephrectomy is the only radical treatment for ccRCC, however metastasis is already present...
4.
Giannakodimos I, Moulavasilis N, Stravodimos K, Fragkiadis E
Curr Med Chem
. 2024 Oct;
PMID: 39473199
No abstract available.
5.
Douroumis K, Katsikatsos P, Kotrotsios K, Moulavasilis N, Fragkiadis E, Stravodimos K, et al.
Cureus
. 2024 Aug;
16(7):e64597.
PMID: 39149627
Hydrocalyx is the obstruction of a renal calyx resulting from infundibulopelvic stenosis or diminution and can be congenital or acquired. A 37-year-old man with a history of preemptive kidney transplantation...
6.
Papadimitriou M, Pilala K, Panoutsopoulou K, Levis P, Kotronopoulos G, Kanaki Z, et al.
Mol Ther Oncol
. 2024 Jul;
32(2):200818.
PMID: 38966038
Bladder cancer (BlCa) is an extensively heterogeneous disease that leads to great variability in tumor evolution scenarios and lifelong patient surveillance, emphasizing the need for modern, minimally invasive precision medicine....
7.
Pilala K, Kotronopoulos G, Levis P, Giagkos G, Stravodimos K, Vassilacopoulou D, et al.
JCO Precis Oncol
. 2024 Apr;
8:e2300414.
PMID: 38579191
Purpose: The lack of personalized management of bladder cancer (BlCa) results in patients' lifelong post-treatment monitoring with invasive interventions, underlying the urgent need for tailored and minimally invasive health care...
8.
Diamantopoulos M, Georgoulia K, Levis P, Kotronopoulos G, Stravodimos K, Kontos C, et al.
Int J Mol Sci
. 2024 Jan;
25(1).
PMID: 38203408
Prostate cancer (PCa) is a global health concern, being a leading cause of cancer-related mortality among males. Early detection and accurate prognosis are crucial for effective management. This study delves...
9.
Papasavva M, Amvrosiou S, Pilala K, Soureas K, Christodoulou P, Ji Y, et al.
Int J Mol Sci
. 2023 Jun;
24(11).
PMID: 37298214
Cellular and molecular immune components play a crucial role in the development and perpetuation of human malignancies, shaping anti-tumor responses. A novel immune regulator is interleukin-37 (IL-37), already shown to...
10.
Grammatikaki S, Katifelis H, Stravodimos K, Bakolas E, Kavantzas N, Grigoriadou D, et al.
In Vivo
. 2023 Apr;
37(3):1103-1110.
PMID: 37103094
Background/aim: Renal cell carcinoma is one of the three most common malignant urologic tumors, with clear cell renal cell carcinoma (ccRCC) representing its most common subtype. Although nephrectomy can radically...